Live
Clinical OMICsMayo Clinic’s REDMOD AI Doubles Early Detection Sensitivity in Pancreatic CancerFierceBiotechIpsen scuttles liver disease candidates from $952M Albireo acquisitionAmgenBiopharma Manufacturing Expands in the U.S.: Amgen, Lilly Double Down on Capacity and Next-Gen Production - BioPharm InternationalEndpoints NewsAmgen, AbbVie say IRA negotiations impacted Q1 salesClinical OMICsAt-Home Blood Test Screens for Early DementiaClinical OMICsGlioblastoma: Testosterone Supplements Linked to 38% Lower Risk of DeathEndpoints NewsLilly plans new $4.5B manufacturing investment in IndianaEndpoints NewsBeOne culls five cancer programs and an autoimmune Phase 2Endpoints NewsLonza looks to ride ADC wave with upcoming factory, workforce expansionFierceBiotechBipartisan PRIMATE Act aims to ban monkey imports to USClinical OMICsEarly Glucagon Elevation Linked to MASLD in Type 2 DiabetesClinical OMICsEpigenetic Markers Link Early-Onset Colon and Rectal Cancer to Specific Pesticide

Archive

Latest Oldest Clear
@FierceBiotech
Total 4
Source FierceBiotech
Query --